SteadyMed Preps for IPO to Fund PAH Drug Delivery Commercialization
News, Pulmonary Hypertension
SteadyMed Therapeutics, an Israeli based specialty pharmaceutical company that focuses on the development of drug product candidates to treat rare and chronic diseases with unmet parenteral (not delivered via the ... Read more